Consistent with data from PRKCQ‐AS1 or MSI2 knockdown, treatment with NSC617570 reduces BMX expression, ERK protein phosphorylation, neuroblastoma cell proliferation and clonogenic capacity. This evidence concerns the gene BMX and neuroblastoma.